1,2-Dichlorobenzene affects the formation of the phosphoenzyme stage during the catalytic cycle of the Ca2+-ATPase from sarcoplasmic reticulum by Javier Vargas-Medrano et al.
RESEARCH ARTICLE Open Access
1,2-Dichlorobenzene affects the formation
of the phosphoenzyme stage during the
catalytic cycle of the Ca2+-ATPase from
sarcoplasmic reticulum
Javier Vargas-Medrano3, Jorge A. Sierra-Fonseca2 and Luis F. Plenge-Tellechea1*
Abstract
Background: 1,2-Dichlorobenzene (1,2-DCB) is a benzene-derived molecule with two Cl atoms that is commonly
utilized in the synthesis of pesticides. 1,2-DCB can be absorbed by living creatures and its effects on naturally-occurring
enzymatic systems, including the effects on Ca2+-ATPases, have been poorly studied. Therefore, we aimed to study the
effect of 1,2-DCB on the Ca2+-ATPase from sarcoplasmic reticulum (SERCA), a critical regulator of intracellular
Ca2+ concentration.
Results: Concentrations of 0.05–0.2 mM of 1,2-DCB were able to stimulate the hydrolytic activity of SERCA in
a medium-containing Ca2+-ionophore. At higher concentrations (0.25–0.75 mM), 1,2-DCB inhibited the ATP hydrolysis
to ~80 %. Moreover, ATP hydrolysis and Ca2+ uptake in a medium supported by K-oxalate showed that starting at
0.05 mM,1,2-DCB was able to uncouple the ratio of hydrolysis/Ca2+ transported. The effect of this compound
on the integrity of the SR membrane loaded with Ca2+ remained unaffected. Finally, the analysis of phosphorylation
of SERCA by [γ-32P]ATP, starting under different conditions at 0° or 25 °C showed a reduction in the phosphoenzyme
levels by 1,2-DCB, mostly at 0 °C.
Conclusions: The temperature-dependent decreased levels of phosphoenzyme by 1,2-DCB could be due to
the acceleration of the dephosphorylation mechanism – E2P · Ca2 state to E2 and Pi, which explains the uncoupling
of the ATP hydrolysis from the Ca2+ transport.
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Background
1,2-Dichlorobenzene (1,2-DCB) is a chlorinated benzene
molecule used as precursor in the synthesis of pesticides.
1,2-DCB can be absorbed and accumulated by humans
and wildlife, and it has been detected in different bio-
logical fluids. Moreover, 1,2-DCB has been linked to se-
vere human health problems such as liver damage and
anemia [1–6]. Oral administration of a radioactively-
labeled 1,2-DCB to rats revealed that it can be distrib-
uted among all tissues, including skeletal muscle. In
addition, it has been shown that DCB molecules can
induce a rise in intracellular Ca2+ in human neuronal
SH-SY5Y cells [7, 8]. Given this evidence, we hypothe-
sized that 1,2-DCB can affect the functionality of skeletal
muscle proteins, particularly the Ca2+-ATPase from
sarcoplasmic reticulum (SERCA), a predominant protein
of skeletal muscle, a hypothesis that has not previously
been explored. SERCA is a large (110-kDa) sarcoplasmic
reticulum protein with 10 transmembrane regions, and
it plays the essential role of reducing the intracellular
Ca2+ concentration by consuming ATP as a source of
energy [9–12]. Each molecule of SERCA protein utilizes
the energy of one ATP molecule to pump 2Ca2+ across
the sarcoplasmic membrane, thus maintaining low cyto-
plasmic Ca2+ concentrations and high intravesicular Ca2+
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concentrations [13, 14]. The catalytic cycle of SERCA in-
volves two main conformational states, E1 with high-Ca
2+
and E2 with low-Ca
2+ affinities [15–17]. In addition, the
three-dimensional structures of the two conformational
stages of SERCA and phosphorylated intermediate (EP)
have been successfully determined [18–22]. Furthermore,
the coupling ratio of both transported Ca2+ and hydro-
lyzed ATP occurs through a sequence of phosphorylated
and non-phosphorylated enzymatic intermediates, with or
without Ca2+ bound to the enzyme, and it has been shown
that EP accumulation can serve as an indicator of enzyme
turnover, which can be affected by a variety of factors such
as temperature, nature of the substrate, Ca2+ concentra-
tion and presence of organic solvents [23].
Given the critical role of SERCA in maintaining appro-
priate cytosolic Ca2+ levels, chemical agents that affect
its functionality can have harmful effects to the overall
cellular function. In this regard, a multitude of molecules
have been described to act as inhibitors of SERCA [24].
Naturally-occurring compounds such as cyclopiazonic
acid (a fungal toxin), and thapsigargin (a sesquiterpene
lactone) are two of the most widely used inhibitors of
SERCA [25–27]. Inorganic compounds such as vanadate,
tungstate and molybdate have also been reported to in-
hibit SERCA activity [28–31]. Other natural compounds
such as ellagic acid and gingerol, which have been de-
scribed to stimulate SERCA activity, have been shown to
be promising therapeutic targets for cardiovascular dys-
function [32, 33]. In addition, several molecules, includ-
ing thapsigargin derivatives and flavonoids are being
developed as potential cancer treatments based on their
SERCA-mediated anti-proliferative and pro-apoptotic ef-
fects [34, 35]. Furthermore, a broad variety of organic
solvents and hydrophobic compounds bearing nucleo-
philic groups have been extensively reported as inhibi-
tors of SERCA activity [36–41]. The inhibitory effect of
these compounds was related to their hydrophobicity,
and notably, they were also able to stimulate SERCA ac-
tivity at certain concentrations. In this study, we provide
evidence, for the first time, that 1,2-DCB affects Ca2+
homeostasis by affecting SERCA, a fundamental Ca2+
modulator. We report here the effect of 1,2-DCB on sev-
eral key features of SERCA, including ATP hydrolytic
activity, the ratio of hydrolysis of ATP/Ca2+ transported,
and the phosphorylation stage (EP) during the catalytic
cycle of this enzyme.
Methods
Chemicals and reagents
[γ-32P]ATP and 45CaCl2 were purchased from Perkin-
Elmer, USA. [3H]Glucose and 45CaCl2 were products of
DuPont NEN. The Ca2+ ionophore A23187 (calcimycin),
EGTA (ethylene glycol-bis (β-aminoethyl ether)-N,N,N’,N’-
tetra acetic acid), Mops (4-morpholinepropanesulfonic
acid), liquid scintillation cocktail (Sigma-Fluor S-4023),
ATP disodium salt, LaCl3, K-oxalate, benzene, 1,2-DCB
was obtained from Sigma, Co. (St. Louis, MO). CaCl2 and
other chemicals ware purchased from J.T. Baker (México).
The Ca2+ ionophore A23187 was dissolved in ethanol.
Benzene and 1,2-DCB were dissolved in methanol.
Ethanol and methanol never reached a concentration
higher than 1 % (v/v) in the reaction media after the
addition of 1,2-DCB or A23187.
Preparation of sarcoplasmic vesicles
SR (sarcoplasmic reticulum) membranes rich in Ca2+-
ATPase (SERCA) were prepared from the low density
SR of skeletal fast-twitch muscle of adult New Zealand
rabbit hind limbs, and preserved in a buffer containing
10 mM Mops, pH 7.0 and 30 % sucrose and stored
at −80 °C as described by Eletr and Inesi [42]. The
sarcoplasmic membrane concentration refers to milligrams
(mg) of total protein per milliliters (ml) and was measured
by the colorimetric procedure described by Lowry et al.
[43]. We used bovine serum albumin as standard protein.
Free Ca2+ concentration in the reaction media
Free Ca2+ concentration was adjusted by adding the ap-
propriate volume of CaCl2 and EGTA to the enzymatic
reaction media [44]. Free Ca2+ concentration was calcu-
lated by the computer program Calcium which is based
on the absolute constant stability for the Ca2+-EGTA
complex, the EGTA protonation equilibrium, Ca2+ li-
gands and media pH [45, 46].
Ca2+-ATPase (SERCA) hydrolytic activity supported by
A23187 or K-oxalate
Initial rates of ATP hydrolysis by SR vesicles were mea-
sured at 25 °C for 5 min (min) by following the liber-
ation of inorganic phosphate (Pi). A typical assay
medium was buffered at pH 7.0, and contained 20 mM
Mops, pH 7.0, 80 mM KCl, 5 mM MgCl2, 1 mM EGTA,
0.967 mM CaCl2 (10 μM free Ca
2+),0.01 mg/ml SR vesi-
cles, 1.5 μM A23187 (to generate leaky vesicles to meas-
ure in min) or 5 mM K-oxalate (no leaks and to
measure in min). A typical reaction was started after the
addition of 1 mM of ATP. Any change in the concentra-
tion of SR protein added to the reaction medium is de-
tailed in the figure captions. The compound 1,2-DCB
was added at the indicated concentrations (0.05–1 mM).
The appearance of Pi from the hydrolysis of ATP medi-
ated by SERCA was evaluated with a molybdovanadate
reagent previously described by Lin and Morales [47].
Experimental details are indicated in the corresponding
figure legends.
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Ca2+ uptake supported by K-oxalate
SERCA is a Ca2+ pump that depends on Mg2+ and the
presence of ATP to transport Ca2+ across of the SR
membrane. For this reason, we studied the Ca2+ trans-
ported by SERCA in the presence of 1,2-DCB. Ca2+
transported by SERCA was measured at 25 °C using
45CaCl2 as a radioactive tracer followed by sample filtra-
tion according with the methods described by Martonosi
and Feretos [48]. The experiment was conducted in a re-
action mixture containing 20 mM Mops, pH 7.0, 80 mM
KCl, 5 mM MgCl2, 1 mM EGTA, 5 mM K-oxalate in-
stead of ionophore A23187 (to keep vesicles intact),
0.967 mM CaCl2 (10 μM free Ca
2+) with 1000 cpm
45CaCl2 per nmol of Ca
2+, and different concentrations
of 1,2-DCB. The reaction contained 0.01 mg/ml of pro-
tein and was started after adding 1 mM of ATP. Ca2+
uptake mediated by SERCA was stopped by filtering the
vesicles in 0.45 μm HA type nitrocellulose membranes
filters (Millipore, Milford, MA). The filters containing
the Ca2+-loaded SR vesicles were washed two times with
2 ml of a buffer containing 20 mM Mops pH 7.0,
80 mM KCl, 5 mM MgCl2 and 1 mM LaCl3. Finally,
45Ca2+ transported was measured by scintillation spec-
troscopy using 3 ml of scintillation cocktail per vial. The
use of radioactive standards allowed us to express the
Ca2+ uptake data as nmol Ca2+/mg of protein.
Membrane integrity test
In order to determine if 1,2-DCB was affecting the
membrane integrity and therefore interfering with Ca2+
measurements, SR vesicles (0.01 mg/ml of protein) were
loaded with 45Ca2+ by performing a Ca2+ transport assay
using the active transport of SERCA as described before
for Ca2+ uptake [48]. The reaction was started with
1 mM of ATP and the reaction ran for 5 s (s) until SR
vesicles were loaded with detectable amounts of Ca2+. In
order to determine if DCB induced vesicle leakage, the
45Ca2+-loaded vesicles were exposed to 1 mM of a 1,2-
DCB right before stopping the reaction by filtration. In
addition, two positive controls were incorporated in sub-
stitution for oxalate: Ca2+ ionophore (1.5 μM of A23187)
in combination with 1 mM 1,2-DCB, and Ca2+ iono-
phore alone. Very importantly, A23187 does not allow
Ca2+ to be accumulated into SR vesicles. For more
details of the experiment please review Ca2+ uptake
supported by oxalate above. The amount of 45Ca2+
loaded into the vesicles was determined by scintilla-
tion spectroscopy.
Ca2+ binding at equilibrium assay
The binding of Ca2+ to SERCA was tested in the absence
of ATP using 45CaCl2. Unbound Ca
2+ was evaluated
from the filter wet volume by using [3H]glucose as a
marker. This approach was used to test the Ca2+ high-
affinity conformational state of SERCA (E1Ca2 stage).
The effect of 1,2-DCB on E1Ca2 state was evaluated at
25 °C for 5 min in a Ca2+-saturating medium containing
20 mM Mops, pH 7.0, 5 mM MgCl2, 80 mM KCl, 0.1 mM
EGTA, 0.105 mM [45Ca]CaCl2 (~5000 cpm/nmol) (10 μM
free Ca2+), 1 mM [3H]glucose (~10,000 cpm/nmol), and
0.2 mg/ml of SR protein. Subsequently, we added different
concentrations of 1,2-DCB. In order to test the effect of
1,2-DCB on E2 stage we used a Ca
2+-free media contain-
ing 20 mM Mops, pH 7.0, 5 mM MgCl2, 80 mM KCl,
0.1 mM EGTA, 1 mM [3H]glucose (~10,000 cpm/nmol),
and 0.2 mg/ml of SR protein, and different concentrations
of 1,2-DCB. The incubation was performed at 25 °C for
5 min. Later, the reaction for E2 stage was supplemented
by adding a buffer containing 20 mM MOPS, pH 7.0,
5 mM MgCl2, 80 mM KCl, 0.1 mM EGTA, 3.15 mM
[45Ca]CaCl2 (~5000 cpm/nmol) and 1 mM [
3H]glucose
(~10,000 cpm/nmol) with a final free-Ca2+ concentration
of 10 μM. Following, the assay was prolonged for 1 min at
25 °C. Samples of 1 ml (0.2 mg of protein) were filtered
under vacuum in 0.45 μm nitrocellulose filters (Millipore,
HA type). Any further washing to determine 45Ca and 3H
associated with the filters and the amount of radioactivity
in the filters was determined by scintillation spectroscopy.
Specific binding of Ca2+ to the SERCA was calculated by
subtracting unbound Ca2+ retained by the filter.
Phosphorylation of SERCA by [γ32]ATP
Maximal levels of EP (phosphorylated enzyme inter-
mediate) were determined using [γ-32P]ATP as a sub-
strate and starting from different incubation conditions:
E1Ca2 -DCB, E2 -DCB and E2[γ-
32P]ATP-DCB in similar
manner as we described in previous work [25, 26]. These
conditions were studied during the enzyme turnover by
mixing equal volumes (0.5 ml) of SR vesicles with the
phosphorylating medium with or without Ca2+ (after
both solutions were mixed, the final volume was 1 ml
and 0.1 mg/ml of SR protein). The SR vesicles (0.2 mg
protein/ml) were suspended in a tube with 0.5 ml of
20 mM Mops, pH 7.0, 80 mM KCl, 5 mM MgCl2, 1 mM
EGTA, 0.967 mM CaCl2 (10 μM free Ca
2+), and 15 μM
A23187. To measure E1Ca2-DCB stage, the reaction
mixture was preincubated with a defined concentration
of 1,2-DCB and the phosphorylation reaction was started
by mixing 0.5 ml of this medium with 20 μl of medium
containing 20 mM Mops, pH 7.0, 80 mM KCl, 5 mM
MgCl2, 1 mM EGTA, 0.967 mM CaCl2, and 1.25 mM
[γ-32P]ATP (50 μM final concentration, ~20,000 cpm/
nmol). When the enzyme (0.2 mg/ml) was in nominally
Ca2+-free medium (E2 -DCB stage), the phosphorylating
medium contained CaCl2 to give 10 μM free Ca
2+ after
mixing. In order to determine if 1,2-DCB was directly af-
fecting the E2ATP in a Ca
2+ free medium, the formation
of the EP stage was started when Ca2+ (to give 10 μM
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free) was added into the reaction medium. Phosphor-
ylation time was 2 s when the enzyme turnover was
studied at 0 °C, and 5 s when studied at 25 °C. The
reaction was started under continuous vortexing and
stopped by adding 1 ml of ice-cold 250 mM perchlo-
ric acid and 2 mM sodium phosphate. Stopped reac-
tions were incubated on ice for 5 min before filtration
through 0.45 μm nitrocellulose filters (Millipore, HA
type). SR vesicles retained by the filters were washed
5 times with ice-cold 250 mM perchloric acid and
2 mM sodium phosphate. Finally, the amount of
radioactivity in the filters was determined by scintilla-
tion spectroscopy. These results are expressed as
nmol EP/milligram of protein.
Statistical analysis
Statistical and kinetic analysis was performed using
Sigma Plot 11 software. Unless otherwise stated, the
experiment values are represented as the mean of at
least three independent experiments, each performed
in triplicate +/− average SE, with statistical signifi-
cance of p < 0.05 determined by t-student’s paired t-test.
Results
Effect of 1,2-DCB on the hydrolytic activity of SERCA
supported by A23187
In order to determine the effect of 1,2-DCB on the
ATP hydrolytic activity of SERCA, we titrated differ-
ent 1,2-DCB concentrations in a typical Ca2+-ATPase
assay where SERCA hydrolyzed ATP to ADP and Pi
as described before. In this experiment we incubated
SR vesicles with A23187, a Ca2+ ionophore, which is
used to generate leaky vesicles (absence of gradient)
in order to avoid saturation of SR vesicles with Ca2+,
which would otherwise stop Ca2+-ATPase activity.
The dose-response curve revealed a biphasic effect of
1,2-DCB on the ATP hydrolytic activity of SERCA:
while lower concentrations of the compound highly
stimulated ATP hydrolysis, 1,2-DCB concentrations
higher than 0.3 mM inhibited SERCA hydrolytic ac-
tivity (Fig. 1). In addition, 0.5 mM of 1,2-DCB re-
duced SERCA activity to 50 % (IC50 = 0.5 mM). To
determine the importance of the Cl atoms on the ef-
fect of the compound on SERCA hydrolytic activity,
we used the benzene molecule, which is the same
ring base structure, but depleted of Cl atoms (Fig. 1,
inset). A dose-response curve was performed by ti-
trating several benzene concentrations, and we found
that the benzene molecule by itself did not affect
SERCA hydrolytic activity at all, indicating that Cl
atoms are involved in the biphasic effect observed on
SERCA hydrolytic activity.
Effect of 1,2-DCB on Ca2+ uptake and ATP hydrolysis ratio
mediated by SERCA and supported by K-oxalate
We next aimed to determine the effect of 1,2-DCB on
Ca2+ uptake mediated by SERCA. Vesicular fragments of
SR exhibit linear rates of Ca2+ transport upon addition
of ATP when equilibrated in the presence of K-oxalate
as a lumenal Ca2+ regulator (non leaky vesicles). In order
to avoid Ca2+ leakage caused by the Ca2+ ionophore
(A23187), we used K-oxalate in both Ca2+-transport and
hydrolytic activity experiments in order to make them
comparable to Ca2+ transport. The dose-response curves
showed that 1,2-DCB did not stimulate Ca2+ uptake me-
diated by SERCA, but in contrast, Ca2+ uptake was
inhibited by DCB concentrations above 0.5 mM until
achieving full inhibition at 1 mM (Fig. 2a). Ca2+ trans-
port cannot be measured in an assay containing a Ca2+
ionophore (as used to measure the ATP hydrolysis)
therefore these experimental conditions did not allow us
to compare the Ca2+ uptake assay with the previously
conducted experiments of hydrolytic activity. The ap-
proach employed for Ca2+ uptake measurement is less
sensitive than the one using Ca2+ ionophore and reduces
enzyme activity by ~1 fold, thus showing less effect of
1,2-DCB (Fig. 2b), however, there were peaks of activa-
tion of approximately 15 and 20 % at DCB concentra-
tions of 0.05 and 0.1 mM, respectively. Nevertheless,
when we compared the ATP hydrolysis results with the
Fig. 1 Effect of 1,2-DCB and benzene on the initial rates of ATP
hydrolysis supported by A23187. The reaction was performed in
a buffer containing 20 mM Mops, pH 7.0, 80 mM KCl, 5 mM
MgCl2, 1 mM EGTA, 0.967 mM CaCl2, and 1.5 μM A23187. The
reaction was conducted by adding 0.01 mg/ml of SR vesicles
with different concentrations of 1,2-DCB (mM) or benzene (mM).
First data point corresponds to Ca2+-ATPase activity without DCB
(control) and it was ~2.6 ± 0.05 μmol Pi/mg∙min
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ones conducted for Ca2+ uptake, we were able to find
a disruption in the Ca2+ uptake/ATP hydrolysis ratio
(calculated by dividing the Ca2+ transport values by
those of ATP hydrolysis), which indicates that the en-
zyme activity ratio was uncoupled, as opposed to nor-
mal physiological conditions during which the enzyme
maintains a coupled ratio of 2Ca2+ for each mol of
ATP hydrolyzed to ADP and Pi (Fig. 2c). The ob-
served ratio appears to confirm that 1,2-DCB concen-
trations greater than 0.05 mM cause a disturbance on
the enzyme activity, an effect that is not observed
only with the hydrolysis.
Given that 1,2-DCB affected Ca2+ uptake mediated by
SERCA, we aimed to determine if 1,2-DCB was also af-
fecting the binding of Ca2+ to SERCA. Direct measure-
ments of 45Ca2+ binding to the non-phosphorylated
enzyme pre-incubated with the compound indicated that
the E1 conformation remained unaffected by treatment
with 1,2-DCB (Fig. 3, open circles). In contrast with the
E1 form, treatment with 1,2-DCB starting from the E2
form prior to binding of Ca2+ affected only ~16 % of the
total Ca2+ bound to the enzyme (Fig. 3, closed circles),
but the levels remained constant with all 1,2-DCB
concentrations.
Fig. 2 The Ca2+-ATPase activity supported by oxalate was uncoupled by 1,2-DCB. The effect of 1,2-DCB on Ca2+/Pi coupling ratio was determined.
The coupling ratio at each DCB concentration was calculated as the ratio between the Ca2+ uptake rate and the ATP hydrolysis rate by SERCA. SR
vesicles (0.01 mg/ml) were equilibrated at 25 °C in a medium containing 5 mM K-oxalate. Hydrolysis rate of ATP (a) or 45Ca2+ uptake
rates (b) were measured at same experimental conditions. c The Ca2+/Pi coupling ratio (calculated by dividing the Ca
2+ transport values
by those of ATP hydrolysis), in presence of different concentrations of 1,2-DCB was uncoupled
Fig. 3 Binding of Ca2+ to SERCA. To test if 1,2-DCB was affecting the
binding of Ca2+ to the enzyme we performed a binding assay as
described in Methods. The complex Ca2+/SERCA (E1Ca2) (o) or
enzyme prior binding to Ca2+ (E2) (●) were exposed to different
concentrations of 1,2-DCB
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Membrane protein-dependent effect of 1,2-DCB and SR
membrane integrity
1,2-DCB is a typical hydrophobic molecule and as
such, it has affinity for hydrophobic environments
such as biological membranes. For this reason, we
used our model of study to investigate the possibility
of 1,2-DCB targeting the SR membranes. First, we
conducted a set of experiments using a high-dose of
1,2-DCB in reactions having 10-fold different amounts
of SR vesicles (0.01–0.1 mg/ml total protein). In these
experiments we tested hydrolysis of ATP mediated by
SERCA and we found that the inhibitory effect of
1,2-DCB was significantly reduced with high amounts
(5–10 folds higher) of SR vesicles (0.05–0.1 mg/ml
total membrane protein), which strongly suggested
that 1,2-DCB molecules were being diluted into the
SR membranes (Fig. 4). These results indicate that
DCB molecules were going from the aqueous envir-
onment of the reaction medium into the membranes,
and when the number of SR vesicles was increased,
there were less 1,2-DCB molecules per SR membrane.
However, this does not confirm if 1,2-DCB was affect-
ing the integrity of the SR membrane. In order to
analyze if 1,2-DCB molecules were disrupting the in-
tegrity of the SR membrane, we loaded SR vesicles
with Ca2+, using a typical Ca2+ uptake assay as previ-
ously described, and 5 s before stopping the reaction
we added 1 mM of 1,2-DCB into the reaction mix
(Fig. 5). SR vesicles treated with 1,2-DCB (open cir-
cles) did not show any difference in levels of accumu-
lated Ca2+ inside of the SR vesicle when compared to
controls (without 1,2-DCB, closed circles), thus dem-
onstrating that 1,2-DCB did not disrupt membrane
vesicles. In addition, we performed a positive control
with a Ca2+ ionophore (A23187) knowing that it pro-
duces leaky vesicles and therefore does not allow Ca2
+ accumulation (Fig. 5, closed and open triangles). As
observed, vesicles with A23187 were only able to ac-
cumulate ~11 % of the total Ca2+ accumulated in the
control at 1 min of filling (100 %). This demonstrates
that, at least in short time exposure, DCB does not
disrupt the SR membrane integrity, which indicates
that the effect of 1,2-DCB on SERCA hydrolytic activ-
ity was due to an effect on SERCA functionality.
Formation of EP stage during the catalytic cycle of SERCA
was inhibited by 1,2-DCB
The following step was to study the formation of EP
stage by ATP during the turnover of SERCA, which is a
crucial step in the catalytic cycle of this enzyme.
Fig. 4 The effect of 1,2-DCB was SR vesicles-dependent. The assay
medium contained 20 mM Mops, pH 7.0, 80 mM KCl, 5 mM MgCl2,
1 mM EGTA, 0.967 mM CaCl2, different SR protein concentrations
(0.01 and 0.10 mg/ml), and 1.5–15 μM A23187 (A23187 was pro-
portionally increased with respect SR total protein). SERCA activity
was assayed at 25 °C in absence of compound as control (white
bars) and with 1 mM 1,2-DCB (gray bars). The reactions started by
the addition of 1 mM ATP. Controls were normalized to 100 % of
Ca2+-ATPase activity and the actual values were 2.6 ± 0.05, 2 ± 0.04, and
1.6 ± 1.3 μM Pi/min/mg. *, p = <0.001, compared to their respectively
control that does not have DCB
Fig. 5 Time-dependent filling of SR vesicles and exposure to 1,2-DCB.
In order to determine the effect of 1,2-DCB on the filling of the vesicles
by SERCA protein, we exposed on the SR membrane, 45Ca2+ uptake
was measured under same conditions described for Ca2+ transport. At
different times in Ca2+ uptake, 1,2-DCB (open circles) was added to the
reaction media before stopping the reaction. The same reaction
without DCB treatment was tested as a control (closed circles).
Two additional positive controls were incorporated in substitution for
oxalate, Ca2+ ionophore (1.5 μM of A23187) was added to the assays
with (closed triangles) or without 1 mM 1,2-DCB (open triangles). Very
importantly, A23187 did not allow Ca2+ to be accumulated into
SR vesicles
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Surprisingly, all the 1,2-DCB concentrations tested con-
siderably reduced the formation of the E1P stage of
SERCA (Fig. 6a). When starting from E1Ca2 plus 1,2-
DCB, and the variation E2 plus 1,2-DCB started with
Ca2+/ATP (inset), the EP levels were drastically reduced:
E1Ca2 with 0.05 mM of 1,2-DCB barely reached 13.04 %
of accumulated EP, with 0.1 and 0.2 mM of 1,2-DCB fur-
ther reducing EP levels to 6.08 and 5.65 %, respectively
and 0.5 mM of the compound completely abolishing EP
accumulation. In the case of E2, the EP levels were simi-
larly affected: 0.05 mM of 1,2-DCB decreased EP to
17.5 %, with 0.1 mM further reducing it to 3.0 %, and
the remaining concentrations showed no EP at all
(Fig. 6a, inset). The results with E2ATP plus 1,2-DCB
started with Ca2+ at 0 or 25 °C were slightly different
(Fig. 6b), and it appears that in this case the observed re-
sult could be more influenced by temperature. However,
beside the temperature difference, a somewhat higher
level of EP can still be observed at 0.05 mM of 1,2-DCB
(Fig. 6b) when compared to the levels observed on Fig. 6a
at the same DCB concentration, suggesting a possible
protective effect by ATP, although experiments carried
at zero degrees using DCB concentrations above
0.1 mM showed complete inhibition of EP formation
(Fig. 6b, closed circles), but EP levels at 25 °C are greater
than those observed at 0 °C. It is worth noting that the
data shown in both figures does follow a similar
trend, that is a consistent reduction of EP levels as
the 1,2-DCB concentration increases.
Discussion
Our data show that 1,2-DCB exerts a dual response of
stimulation and inhibition in SERCA hydrolytic activity
supported by A23187 (Fig. 1). Similar effects of activa-
tion and inhibition of SERCA caused by other hydropho-
bic compounds have been reported in the literature, and
possible explanations include alterations in the lipid en-
vironment of the enzyme, as well as accessing sensitive
domains of the pump due to their hydrophobic proper-
ties [49–51]. The 1,2-DCB molecule possesses two Cl
atoms in the benzene ring. In order to test the import-
ance of the Cl atoms on the effect of this molecule on
SERCA, we used benzene (which lacks Cl atoms) and we
were able to avoid the inhibitory and stimulatory effects
on SERCA activity produced by 1,2-DCB (Fig. 1). Our
data supports a clear relation between the structure of
1,2-DCB and the effect produced on the ATP hydrolytic
activity, since the absence of Cl atoms does not cause
any effect on SERCA. Similar conclusions have been pre-
viously reported regarding the effects caused by the
presence of electronegative groups [52–54]. Moreover,
hydrophobic molecules can interact with hydrophobic
Fig. 6 Effect of 1,2-DCB on functional states of SERCA as determined by ATP phosphorylation. SR vesicles at 0.1 mg of protein/ml were incubated
at 25 °C in a medium containing: a 20 mM Mops, pH 7.0, 80 mM KCl, 5 mM MgCl2, 15 μM A23187, 0.1 mM EGTA, 10 μM free Ca
2+, and a certain
1,2-DCB concentration starting with 50 μM [γ-32P]ATP (●). Inset: The E2 + 1,2-DCB prior phosphorylation was starting with 10 μM free Ca2+
and 50 μM [γ-32P]ATP (○). The phosphorylation in each case was maintained for 2 s at 0 °C. b For phosphorylation initiating from E2ATP
Ca2+ free, the enzyme (0.1 mg of protein/ml) was first treated with 1,2-DCB in a media containing 20 mM Mops, pH 7.0, 80 mM KCl, 5 mM MgCl2,
15 μM A23187, 0.1 mM EGTA, followed by phosphorylation at 0 °C or 25 °C by adding [γ-32P]ATP and 10 μM free Ca2+. For more details see Methods
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domains in the membrane proteins, thus affecting en-
zyme functionality [37, 53, 55].
We also addressed the possibility of 1,2-DCB affecting
the activity of binding/translocation of Ca2+ by SERCA.
Surprisingly, a 1 mM concentration of 1,2-DCB fully
inhibited Ca2+ uptake without affecting Ca2+-binding,
which suggests that the binding of Ca2+ is not a major
problem for the inhibition of Ca2+ transport. However,
this is indicative that 1,2-DCB is affecting the Ca2+ sen-
sitive conformation of the enzyme to a lesser extent
(Figs. 2a and 3 respectively). Nevertheless, our data of
binding of Ca2+ suggested that Ca2+ was able to bind to
the enzyme in turnover conditions almost at normal
levels, even when Ca2+ uptake was completely inhibited
at the highest DCB concentration. Therefore, it was ne-
cessary to study the hydrolytic activity of SERCA under
the same conditions used for the Ca2+ transport assay,
using K-oxalate instead of the Ca2+ ionophore. When
intravesicular Ca2+ levels get higher (~2–3 mM), Ca2+
reacts with oxalate to form calcium oxalate thus precipi-
tating inside of the intact vesicle as crystals [13], which
allows us to measure the enzyme activity in min. Sur-
prisingly, we found that the hydrolytic activity of SERCA
under these same conditions was still stimulated, but
not inhibited at the same concentrations tested before
(Fig. 3b). This may be due to the different experimental
conditions such as the presence of ionophore, which
allows the system to function more efficiently. The
Ca2+-ionophore acts as a freely mobile carrier that
transports Ca2+ across the membrane, and it is possible
that it is acting simultaneously with the 1,2-DCB, stimu-
lating the pump due to increased membrane permeability
and absence of gradient [13, 56, 57]. This could explain
why activation and inhibition are more pronounced when
measured with the Ca2+-ionophore than when measured
with K-oxalate, where the vesicle interior is not gradient-
free. We also found that the Ca2+/Pi ratio was partially
uncoupled at 1,2-DCB concentrations between 0.05 and
0.5 mM, and fully uncoupled at 1 mM. This phenomenon
of uncoupled Ca2+-ATPase with a lower Ca2+/Pi ratio has
been previously described in terms of the increased
thermogenic activity that occurs when using intact vesi-
cles [13–15], where it was found that after Ca2+ satur-
ation, ~82 % of the hydrolytic activity is uncoupled
from the Ca2+ transport, thus decreasing the Ca2+/Pi ratio.
Previous reports showed that non-polar organic
solvents facilitate the incorporation of hydrophobic
compounds to cell membranes, and that enzymatic
stimulation or inhibition is related to both solvent
and membrane protein quantity [38, 49]. In agree-
ment with the literature, 1,2-DCB affects SERCA ac-
tivity by sharing these features, as we further
demonstrated that the inhibitory effect of 1,2-DCB
was SR membrane-dependent (Fig. 4). This could be
due to a partitioning effect of the DCB into the
membrane fraction, which indicates that activation or
inhibition is dependent on membrane composition
and protein concentration. Organic solvents can re-
duce the inhibition of SERCA by certain drugs, which
explains how hydrophobic drugs can move to a lipid
environment in the membrane, thus causing enzyme
inhibition [49, 50, 58]. Data from Lax et al. [59]
showed that the addition of phosphatidylcholine lipo-
somes to SERCA reactions caused a decrease in the
inhibitory effect of the fungicide miconazol. 1,2-DCB
shares similar features to those of miconazole and
therefore, we believe that our data indicates that DCB
is going into the SR vesicles because of its hydropho-
bic properties.
The Ca2+ uptake assay employed in this study mea-
sured accumulated Ca2+ inside the SR vesicles [48, 60].
However, if 1,2-DCB disrupts the time required to fill
the vesicles with Ca2+, this may be reflected as an inhib-
ition on the accumulated Ca2+ due to a loss of Ca2+
caused by vesicle damage. Molecules such as 1,2-DCB
can target SR membranes affecting the filling time of SR
vesicles by the SERCA pump. For example, hexachloro-
cyclohexane, a hydrophobic compound, was shown to
affect the activity of membrane proteins by disrupting
the lipid bilayer [55]. For this reason, we filled out SR
vesicles with Ca2+ using the active transport of SERCA,
followed by the addition of a high concentration of DCB
(1 mM) 5 s before stopping the reaction. In agreement
with our previous findings, 1,2-DCB was unable to de-
crease the levels of accumulated Ca2+ when compared to
controls (without DCB) (Fig. 5). Given that vesicle filling
occurs in less than 1 s, which is the physiological time
during which muscle relaxation occurs [15], we selected
a longer vesicle filling time. This data clearly demon-
strates that 1,2-DCB is not affecting the vesicle filling
time by causing disturbances of the SR membrane. This
was supported by our a positive control using Ca2+ iono-
phore A23187 (absence of gradient) alone or with 1 mM
1,2-DCB, which did not allow accumulation of Ca2+ in-
side the SR vesicles (Fig. 5). This phenomenon is re-
ferred to in the literature as “leaky vesicles”, since this
system allows the efflux of luminal Ca2+, thus obtaining
faster efflux [61, 62]. It was interesting to find that the
SR membrane was not disrupted, which supports our
findings that 1,2-DCB is causing uncoupling of the
Ca2+/Pi ratio. Considering this phenomenon applied
to a biological system, we can refer to the thermogenic
activity previously proposed by Inesi and Tadini-
Buoninsegni [15], where SERCA1 uncoupling interferes
with the decrease of cytosolic Ca2+ and the subsequent re-
laxation of muscle fibers. If we take into account that vesi-
cles are filled with Ca2+ in less than 1 s, a sufficient
concentration of luminal Ca2+ would not be reached, thus
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preventing the dissociation of the E2-P
.Ca2 form. This
phenomenon could not lead to thermogenic activity due
to a basal state of the pump. The Ca2+ leakage from the
pump could occur if the luminal Ca2+ concentration
reached such high levels that both its E2-P
.Ca2 dissociation
constant and the cytosolic Ca2+ concentrations would re-
main above the required levels to achieve maximal pump
activation, which could occur under prolonged muscle ac-
tivity. Even though the cytosolic Ca2+ levels can remain
high due to multiple action potentials, this does not ap-
pear to be our case, since we have no evidence of pump
overload (Figs. 2a and 5).
In order to get more insights into the mechanism
by which 1,2-DCB caused uncoupling of the SERCA
activity, we studied the E1P step of the enzyme. Our
results demonstrated that 1,2-DCB decreased the EP
stage formation but was influenced by temperature
when starting from E2ATP, even when our previous
experiments showed that 1,2-DCB produced a high
rate of ATP hydrolysis. Our initial expectation was to
observe elevated levels of EP by ATP, since it is com-
mon that hydrophobic molecules affect the E2 state of
SERCA which prevents or decreases the transition to
the E1 stage [25, 63]. Our data of EP inhibition sug-
gests that 1,2-DCB (Fig. 6) could be affecting the E2
step. Similar examples of this phenomenon are found
in the literature [15, 49, 51, 64, 65]. Taken together,
the inhibition of the EP stage and our previous re-
sults could explain why an uncoupled Ca2+/Pi ratio
was observed, even when Ca2+ is binding to the en-
zyme in the presence of 1,2-DCB. Phosphorylation of
the enzyme is necessary for the appropriate Ca2+
transport across the SR membrane. Therefore, it is
possible that a Ca2+ slippage process is taking place,
where ATP hydrolysis is occurring without the subse-
quent accumulation of the transient E1P form and
without Ca2+ transport, with Ca2+ “slipping” into the
outside of the vesicles. This can be affected by several
factors such as time, temperature, enzymatic stage
and in our case the DCB concentration [66, 67] Our
data shows that at 25 °C, EP levels were increased
(Fig. 6b). However, the measurements followed the
same pattern of EP decrease with increasing DCB
concentration. Regarding the EP measurements con-
ducted at 0 °C, which seem to go against the litera-
ture, it is well established that high levels of EP are
obtained at low temperatures (0 °C) due to the rapid
transition of the limiting E1P
.Ca2 step to E2P
.Ca2, and
the subsequent Ca2+ translocation that leads to the
EP decomposition [68], in other words, the phos-
phoenzyme formed from ATP is more sensitive to
ADP at 0 °C than at 30 °C, thus confirming that ATP
hydrolysis coupled to Ca2+ efflux and the ATP↔Pi
exchange reaction are inhibited at 0 °C [69]. However,
the experiments starting from E2ATP showed higher
levels of accumulated EP, but these experiments were
conducted at 0 and 25 °C, where A23187 is also
present (although protein concentration, time and
ATP are different). At 0.05 mM DCB, ~30–40 % of
accumulated EP can be observed at both tempera-
tures, indicating that ATP could be protecting the
enzyme from inhibition. However, higher DCB con-
centrations (0.1 mM and subsequent) caused a drastic
decrease in EP levels (Fig. 6b, filled circles). Other
factors that could affect the E1P to E2P transition in-
clude detergents and the microviscosity of the lipid
environment of the ATPase [70]. Temperature is an-
other important factor that could potentially affect
this transition, as it has been demonstrated that at
21 °C the E1P to E2P isomerization is rapidly affected
at high KCl concentrations [71]. Temperature is also
important for compound solubility in aqueous solu-
tions, as it has been shown that the solubility of
aroma compounds (such as methyl ketones, ethyl es-
ters, aldehyde and alcohol) decreases when incubated
on ice as the concentration of the compound is in-
creased, which could contribute to explain the effect
of temperature and DCB solubility at 0 and 25 °C in
the EP measurements [72].
Conclusions
Our data demonstrates that 1,2-DCB affects the ATP
hydrolytic activity of SERCA, causing both stimulation
and inhibition of ATP hydrolysis. This dual effect caused
by 1,2-DCB fits it into a common pattern displayed by
several other hydrophobic compounds. We also found
that 1,2-DCB partially inhibited Ca2+ transport and EP
stage formation due to uncoupled enzyme activity, even
without affecting the Ca2+ bound to the enzyme. Finally,
to the best of our knowledge, this is the first study de-
signed to study the effect of 1,2-DCB, a chemical that is
widely found in the environment, on the functionality of
SERCA proteins, and thus the data presented here not
only provide insights into the molecular mechanisms of
the enzyme’s catalytic cycle, but on the possible toxic ef-
fects caused by 1,2-DCB.
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